Interleukin-4 and interleukin-13 as possible therapeutic targets in systemic sclerosis

G Gasparini, E Cozzani, A Parodi - Cytokine, 2020 - Elsevier
Systemic sclerosis (SSc) is an autoimmune disease characterized by fibrosis of skin and
internal organs. Its pathogenesis, which is still poorly understood, features three main …

Interleukin-4 and interleukin-13 as possible therapeutic targets in systemic sclerosis

G Gasparini, E Cozzani, A Parodi - Cytokine, 2020 - pubmed.ncbi.nlm.nih.gov
Systemic sclerosis (SSc) is an autoimmune disease characterized by fibrosis of skin and
internal organs. Its pathogenesis, which is still poorly understood, features three main …

[引用][C] Interleukin-4 and interleukin-13 as possible therapeutic targets in systemic sclerosis

G Gasparini, E Cozzani, A Parodi - Cytokine, 2020 - cir.nii.ac.jp

Interleukin-4 and interleukin-13 as possible therapeutic targets in systemic sclerosis.

G Gasparini, E Cozzani, A Parodi - Cytokine, 2019 - europepmc.org
Systemic sclerosis (SSc) is an autoimmune disease characterized by fibrosis of skin and
internal organs. Its pathogenesis, which is still poorly understood, features three main …